CASE Issues Statement & Letter to Senate on Danger of Democrats’ Latest Drug Pricing Plan
July 21, 2022 Today, Gerard Scimeca, Chairman of Consumer Action for a Strong Economy, issued the following statement and...
Why Congress Shouldn’t Meddle with the Market Forces in Medicare Part D
July 8, 2019 43 million seniors in the United States rely on Medicare Part D to provide them with the...
CASE Joins Free-Market Effort on Farm Bill, Sugar Policy
CASE today announced its inclusion in a free-market coalition in support of President Trump’s goal of global trade that eliminates...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/